In the majority of the adult skeleton, bone formation is confined to specific remodeling sites. Whether bone is lost or gained will depend on the extent of bone formation in each one of these sites which is thought to be regulated by local growth factors. Of the several growth factors present in bone, there is now sufficient evidence to document an important role for insulin-like growth factors (IGFs) in the local regulation of bone formation. Our past studies on regulation of IGF actions in bone have led to the purification and characterization of two new IGF binding proteins; IGFBP-4 and IGFBP-5. The primary goal of this project is to extend our past work and focus on the regulation and action of IGFBP-4 and IGFBP-5 and their proteases since IGFBP-4 is the major IGFBP produced by human bone cells and inhibits IGF induced bone cell proliferation and IGFBP-5 is the major IGFBP stored in bone and stimulates IGF induced bone cell proliferation. In this regard, we will test 3 relevant hypothesis: 1) That systemic and local effectors of bone metabolism could modulate IGF action by regulating the concentration of IGFBP-4 and IGFBP-5 at one or more regulatory sites in the metabolic sequence of IGFBP synthesis, secretion and degradation. To determine the cause and effect relationship between IGFBP production and modulation of bone cell proliferation, we will use an antisense oligodeoxyribonucleotide approach to evaluate the role of IGFBP-4 and IGFBP-5 in mediating the effects of selected systemic hormones. 2) That the concentration of IGFBP-4 and IGFBP-5 in the bone cell microenvironment is regulated in part by production of IGFBP specific proteases. In this regard, we propose studies to purify and characterize the recently discovered putative IGFBP-4 and IGFBP-5 proteases from human bone cell conditioned medium and determine the role of these proteases in regulating the concentration of IGFBP-4 and IGFBP-5. 3) That IGFBP-4 and IGFBP-5 modulate the biological effects of IGFs in bone cells either by altering the affinity of IGFs for IGF receptors or by acting through a IGFBP specific cell surface receptor. For these studies, we will use partially purified IGF receptors and IGF mutants that bind to IGF receptors but not to IGFBP-4 or IGFBP-5 and vice versa. All of the proposed work will involve human IGFBPs and IGFBP proteases using human osteoblast like cells. It is anticipated that these studies will provide valuable information regarding the regulation and actions of IGFBP-4 and IGFBP-5 in bone and should lead to major insights regarding the pattern of responses that are seen by different agents within the IGF system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR031062-13
Application #
2078749
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1981-08-01
Project End
1997-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
13
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Loma Linda University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Wergedal, Jon E; Kesavan, Chandrasekhar; Brommage, Robert et al. (2015) Role of WNT16 in the regulation of periosteal bone formation in female mice. Endocrinology 156:1023-32
Alshbool, Fatima Z; Mohan, Subburaman (2014) Emerging multifunctional roles of Claudin tight junction proteins in bone. Endocrinology 155:2363-76
Simon, Nathan C; Barbieri, Joseph T (2014) Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion. J Biol Chem 289:10650-9
Alshbool, Fatima Z; Mohan, Subburaman (2014) Differential expression of claudin family members during osteoblast and osteoclast differentiation: Cldn-1 is a novel positive regulator of osteoblastogenesis. PLoS One 9:e114357
Kim, Ha-Young; Alarcon, Catrina; Pourteymour, Sheila et al. (2013) Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice. Am J Physiol Endocrinol Metab 304:E531-7
Xing, Weirong; Liu, Jeff; Cheng, Shaohong et al. (2013) Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis. J Bone Miner Res 28:1962-74
Linares, Gabriel R; Brommage, Robert; Powell, David R et al. (2012) Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation. J Bone Miner Res 27:1553-65
Kiepe, Daniela; Rüth, Eva-Maria; Blum, Werner F et al. (2010) The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patients. Pediatr Nephrol 25:659-67
Ohlsson, Claes; Mohan, Subburaman; Sjögren, Klara et al. (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30:494-535
Linares, Gabriel R; Xing, Weirong; Govoni, Kristen E et al. (2009) Glutaredoxin 5 regulates osteoblast apoptosis by protecting against oxidative stress. Bone 44:795-804

Showing the most recent 10 out of 147 publications